Jan. 13, 2020 -- ATIF Holdings Limited (Nasdaq: ATIF, the “Group”, “ATIF” or “we”) announces its client, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding Group Limited (Nasdaq: QLI, “Qilian”), whose ordinary shares have been approved for listing on the Nasdaq Global Market and has commenced trading on January 12, 2021.

Qilian announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share on January 12, 2021. Qilian expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, Qilian has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.